Articles

‘Her First 100K’ founder Tori Dunlap says investing right now is about managing your own panic

For Financial Literacy Month, Tori Dunlap spoke with MarketWatch about the investing hurdles women and young people face right now

Americans are ‘doom-buying’ coffee, olive oil and soap. What’s the one thing I should stockpile to avoid tariff price hikes?

Some purchases have echoes of the early days of the pandemic.

Apple hasn’t gotten an ‘all clear’ on tariffs, but its stock is still surging

While Trump promises new tariffs for tech products, Apple seems to have avoided the worst-case scenario, as smartphones are exempt from the current reciprocal tariffs against China.

This is America’s ‘magic number’ for retirement – and it’s lower this year

Workers should replace 80% of their income for each year of retirement, new research suggests

Wegovy, Zepbound makers’ stocks rally as a weight-loss-drug competitor drops out

Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and Zepbound maker Eli Lilly a lift.

Goldman Sachs sees ‘strong’ earnings, powered by equities-trading revenue

Goldman Sachs reported revenue drops in two of its three main business lines, but trading revenue was enough to satisfy investors.

Central banks almost never say they intervene in currency markets. In a survey, half said they do.

Central banks rarely announce their interventions in currency markets — but one survey suggests they are very active despite pressure to keep out.

I begged my adviser to sell amid the market turmoil. It took him days and I lost $20,000. Can I sue?

“If he had moved my money out of the market weeks ago, much of my loss could have been prevented.”

World to America: We’re not dependent on trade with you anymore

The U.S. is not the trade titan that Trump believes it is.

Investors are jittery about earnings — and that’s opening up big opportunities, say Goldman strategists

Looking at the demand for put over call options, fear remains at extreme levels despite the 90-day delay in most tariffs, say strategists led by John Marshall, head of derivatives research at Goldman Sachs.

America’s generic-drug crisis can be fixed in two words: pharma tariffs

Strong U.S. production isn’t just good economic policy; it’s about national security and public health.

‘The whole thing feels predatory’: My grandma, 97, pays $170 a month for a $10,000 life-insurance policy. Should we stop payments?

“After what quickly became a heated discussion, the agent advised me that canceling the policy would end any chance of a payout.”
1 165 166 167 168 169 2,159